Achilles Therapeutics (ACHL) Appoints Bernhard Ehmer to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. USO
3. SPY
4. BBIO
5. NVDA
6. OPCH
7. SKYD
8. GOOGL
9. AMD
10. STZ

Go back to Achilles Therapeutics (ACHL) Appoints Bernhard Ehmer to its Board

Achilles Therapeutics Appoints Bernhard Ehmer to Board of Directors

May 4, 2022 8:00 AM EDT

LONDON, May 04, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced the appointment of Bernhard Ehmer, MD, to the Board as a Non-Executive Director. Bernhard joins Achilles with a strong track record in international R&D, regulatory and commercial activities.

Bernhard is a veteran biotechnology and pharmaceutical executive with more than three decades in senior leadership roles. He most recently served as CEO of Biotest AG in Germany and also served as... More